Y200-3082 Screening compound: 6-bromo-4-(4-methylpiperazine-1-carbonyl)-2-phenylquinoline

Y200-3082 Screening compound: 6-bromo-4-(4-methylpiperazine-1-carbonyl)-2-phenylquinoline
Y200-3082 Screening compound: 6-bromo-4-(4-methylpiperazine-1-carbonyl)-2-phenylquinoline alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-3082
6-bromo-4-(4-methylpiperazine-1-carbonyl)-2-phenylquinoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-3082

Molecular Formula

C21H20BrN3O (C21 H20 BrN3 O)

Compound Name

6-bromo-4-(4-methylpiperazine-1-carbonyl)-2-phenylquinoline

IUPAC name

6-bromo-4-(4-methylpiperazine-1-carbonyl)-2-phenylquinoline

SMILES

CN(CC1)CCN1C(c1c(cc(cc2)Br)c2nc(-c2ccccc2)c1)=O

InChI

InChI=1S/C21H20BrN3O/c1-24-9-11-25(12-10-24)21(26)18-14-20(15-5-3-2-4-6-15)23-19-8-7-16(22)13-17(18)19/h2-8,13-14H,9-12H2,1H3

InChI Key

FLCXCCWJTJUYGX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02373381

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

410.31

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

4.362

Distribution Coefficient, logD

4.232

Water Solubility, LogSw

-4.30

Polar Surface Area

28.422

Acid Dissociation Constant (pKa)

27.74

Base Dissociation Constant (pKb)

6.95

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.80

Y200-3082 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Anti-Inflammatory Library (24602 compounds)

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

Autophagy-Targeted Library (4564 compounds)

CNS BBB Library (22607 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Nervous system
  • Cardiovascular
Mechanism of action:
  • Epigenetic
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with Y200-3082 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-3082?
Check Price and Availability of Y200-3082, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-3082 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-3082
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-3082
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-3082 available by request